Company: PMVP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001193125-25-276003
Chunk: 0

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 0
---
PMV Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(in thousands, except share and per share amounts)

     September 30,2025 (unaudited)

     December 31,2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     36,337

     $
     40,876

     Marketable securities, current

     92,913

     128,578

     Prepaid expenses and other current assets

     3,199

     6,204

     Total current assets

     132,449

     175,658

     Property and equipment, net

     255

     409

     Marketable securities, noncurrent

     —

     13,843

     Right-of-use assets

     891

     1,143

     Other assets

     249

     235

     Total assets
      
     $
     133,844

     $
     191,288

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     3,399

     $
     6,579

     Accrued expenses

     8,515

     7,439

     Operating lease liabilities, current

     390

     352

     Total current liabilities

     12,304

     14,370

     Operating lease liabilities, noncurrent

     541

     838

     Total liabilities

     12,845

     15,208

     Stockholders’ equity:

     Preferred stock, $0.00001 par value, 5,000,000 shares authorized at September 30, 2025 and December 31, 2024. No shares issued or outstanding at September 30, 2025 and December 31, 2024.

     —

     —

     Common stock, $0.00001 par value, 1,000,000,000 shares authorized; 52,993,238 and 51,935,134 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively.

     —

     —

     Additional paid-in capital

     549,325

     544,653

     Accumulated deficit

     (428,417
     )

     (368,712
     )

     Accumulated